Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
An ethical case explores whether a medical student doing a radiology rotation has a duty to inform a patient whose chest x-ray shows bony metastases that was not caught by the original radiologist or mentioned in the ED chart.